OEL (HOLDINGS) LIMITED
SINCE 1984
(SGX:584)
REG: 198403368H
HIFU MedTech Pte. Ltd. Introduction
HIFU MedTech Pte. Ltd. is a joint venture company registered in Singapore by AJJ Health Care Management Pte. Ltd., a wholly-owned subsidiary of OEL (Holdings) Limited (SGX: 584), and Shanghai Suntec Co., Ltd. for business development. The aim is to carry out the entire end-to-end industrial chain of R&D, manufacturing and installation, medical services and equipment after-sales service in Singapore. Its marketing goal is to start from Singapore and gradually sell to Southeast Asia (outside China) and European and American markets. At present, the HIFU-2001 High-Intensity Focused Ultrasound tumor treatment system will be launched soon.
The core of the industrial chain is Dr. Ye Wenzheng of Shanghai Longjian Medical Management Co., Ltd., a wholly-owned subsidiary of OEL (Holdings) Limited (SGX: 584), AJJ Health Care Management Pte. Ltd., another company holding 51%. As a top well-known doctor in China, Dr. Ye has served as Chief Physician, Professor, Director of the Department of Hematology, Changhai Hospital affiliated to the Second Military Medical University of the Chinese People's Liberation Army, Vice Minister and Minister of the training department of the Second Military Medical University, and Vice-principal of the Second Military Medical University. He used to be a Senior Researcher of Shanghai Academy of Economic Sciences and Deputy Director of Shanghai Medical Research Center.
Dr. Ye Wenzheng
Currently the legal person of Shanghai Longjian Management Co., Ltd. and one of the founders of HIFU medical technology principles. Has served as Chief Physician, Professor, Director of the Department of Hematology, Changhai Hospital affiliated to the Second Military Medical University of the Chinese People's Liberation Army, Vice Minister and Minister of the training department of the Second Military Medical University, and Vice-principal of the Second Military Medical University, the rank of Major General.
Dr. Ye used to be a Senior Researcher of Shanghai Academy of Economic Sciences and Deputy Director of Shanghai Medical Research Center. He has been engaged in clinical medicine, medical affairs management, teaching management, college management, etc., and has accumulated very rich clinical experience and management experience. In recent years, he has been devoted to the theoretical research and practical operation of diversified medical treatment, and has a deep understanding of social capital's participation in the operation of investment in medical institutions.
Dr. Ye once created three firsts in the field of Chinese medicine:
The first case of allogeneic fetal liver transplantation to treat leukemia in China;
The first diagnosis of light chain disease in China;
The first pelger-hurt leukocyte abnormality found in China.
Vice-principal Ye has trained countless leaders and outstanding experts in the military and medical circles.
HIFU-2001 High-Intensity Focused Ultrasound Tumor Treatment System
8 Temasek Boulevard, #23-02 Suntec Tower 3 Singapore 038988
+(65) 6235 5091
general@ohldg.com
CONTACT US
OEL (HOLDINGS) LIMITED
(SGX:584)
REG: 198403368H
